麻豆社

I'm a pharmaceutical company

936X874 Disclosure

What do听you need to know?

All 麻豆社members and any pharmaceutical company that听follows听听are required to disclose annually transfers of value - certain payments and benefits in kind -听made to healthcare professionals (HCPs) and healthcare organisations (HCOs).听

Why do pharmaceutical companies need to disclose?

The disclosure of certain transfer of value made to听HCPs and HCOs听is about bringing further transparency to the relationship between the pharmaceutical industry and those听it works with.

It is a relationship that is critical to the future of medical innovation and patient care and as such, should meet the high expectations of patient and wider stakeholders.

Disclosing details of certain payments and benefits in kind鈥嬧�嬧�� made to individual HCPs and HCOs is part of a Europe-wide initiative to increase transparency. It also builds on the 麻豆社Code of Practice requirements to disclose certain payments which have been made in total since 2012.

Related content in this section:

Last modified: 01 July 2024

Last reviewed: 01 July 2024